Total Payments
$17,646
2024 Payments
$6,418
Companies
58
Transactions
1,125
Medicare Patients
9,114
Medicare Billing
$458,175
Payment Breakdown by Category
Food & Beverage$13,616 (77.2%)
Other$3,848 (21.8%)
Education$182.36 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,616 | 1,114 | 77.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,848 | 4 | 21.8% |
| Education | $182.36 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $3,992 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,427 | 52 | $0 (2024) |
| Amgen Inc. | $1,373 | 150 | $0 (2024) |
| Novo Nordisk Inc | $1,336 | 107 | $0 (2024) |
| PFIZER INC. | $1,159 | 110 | $0 (2024) |
| Lilly USA, LLC | $912.38 | 104 | $0 (2024) |
| ABBVIE INC. | $895.69 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $778.99 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $630.65 | 77 | $0 (2023) |
| Merck Sharp & Dohme LLC | $528.68 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,418 | 154 | Phathom Pharmaceuticals, Inc. ($3,992) |
| 2023 | $2,063 | 160 | AbbVie Inc. ($275.52) |
| 2022 | $1,665 | 150 | ABBVIE INC. ($179.12) |
| 2021 | $1,791 | 154 | AbbVie Inc. ($186.99) |
| 2020 | $1,265 | 100 | Amgen Inc. ($261.71) |
| 2019 | $1,440 | 129 | PFIZER INC. ($276.81) |
| 2018 | $1,462 | 140 | Novo Nordisk Inc ($266.01) |
| 2017 | $1,542 | 138 | Amgen Inc. ($164.30) |
All Payment Transactions
1,125 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.27 | General |
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Biological | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $67.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $46.24 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,156 | 5,306 | $360,943 | $94,588 |
| 2022 | 35 | 2,246 | 5,669 | $346,662 | $99,794 |
| 2021 | 35 | 2,442 | 6,086 | $382,946 | $151,604 |
| 2020 | 32 | 2,270 | 5,305 | $313,377 | $112,189 |
Total Patients
9,114
Total Services
22,366
Medicare Billing
$458,175
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 1,980 | $66,360 | $36,347 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 191 | 426 | $113,307 | $17,389 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 90 | $33,390 | $4,319 | 12.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 163 | 267 | $9,879 | $3,454 | 35.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 180 | 401 | $3,893 | $3,262 | 83.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 165 | 311 | $9,019 | $3,201 | 35.5% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2023 | 20 | 21 | $7,059 | $2,935 | 41.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 125 | 158 | $6,004 | $2,572 | 42.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 167 | 336 | $7,056 | $2,549 | 36.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 32 | $21,580 | $1,911 | 8.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 65 | $4,347 | $1,845 | 42.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $1,940 | $1,647 | 84.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 66 | 68 | $2,144 | $1,441 | 67.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 77 | 152 | $3,800 | $1,432 | 37.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 42 | 49 | $3,969 | $1,421 | 35.8% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 20 | 40 | $4,800 | $1,175 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 28 | $5,208 | $1,034 | 19.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $34,364 | $902.46 | 2.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 36 | 37 | $3,180 | $865.84 | 27.2% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 38 | 38 | $1,710 | $718.96 | 42.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 49 | 69 | $1,311 | $594.82 | 45.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 66 | $4,408 | $579.63 | 13.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 86 | 86 | $1,032 | $525.46 | 50.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 11 | 62 | $1,798 | $509.40 | 28.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 86 | 86 | $1,204 | $436.88 | 36.3% |
About Dr. Michael Brenner, M.D
Dr. Michael Brenner, M.D is a Family Medicine healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114992674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Brenner, M.D has received a total of $17,646 in payments from pharmaceutical and medical device companies, with $6,418 received in 2024. These payments were reported across 1,125 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,616).
As a Medicare-enrolled provider, Brenner has provided services to 9,114 Medicare beneficiaries, totaling 22,366 services with total Medicare billing of $458,175. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location South Sioux City, NE
- Active Since 02/20/2006
- Last Updated 12/03/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114992674
Products in Payments
- VOQUEZNA (Drug) $3,992
- FARXIGA (Drug) $755.84
- ELIQUIS (Drug) $660.98
- Ozempic (Drug) $581.66
- VRAYLAR (Drug) $525.41
- JARDIANCE (Drug) $512.00
- EVENITY (Biological) $447.56
- Kerendia (Drug) $442.27
- UBRELVY (Drug) $379.98
- MOUNJARO (Drug) $339.69
- Otezla (Drug) $338.11
- Aimovig (Biological) $322.42
- ZENPEP (Drug) $271.12
- TRELEGY ELLIPTA (Drug) $245.24
- Rybelsus (Drug) $237.15
- NEXLETOL (Drug) $228.37
- BREZTRI (Drug) $218.19
- Prolia (Biological) $218.10
- Vascepa (Drug) $215.20
- CHANTIX (Drug) $212.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Sioux City
Michael Hattan, Md, MD
Family Medicine — Payments: $11,240
Family Medicine $11,240
Thomas Wente, Do, DO
Family Medicine — Payments: $10,128
Family Medicine $10,128
Melissa Austreim-Krell, M.d, M.D
Family Medicine — Payments: $8,652
Family Medicine $8,652
David Ensz, M.d, M.D
Family Medicine — Payments: $7,676
Family Medicine $7,676
Suhair Najdawi, Md, MD
Family Medicine — Payments: $4,040
Family Medicine $4,040
Austin Granatowicz, Md, MD
Family Medicine — Payments: $2,343
Family Medicine $2,343